» Articles » PMID: 2226354

Body Temperature Alters the Lipid Composition of Pulmonary Surfactant in the Lizard Ctenophorus Nuchalis

Overview
Journal Exp Lung Res
Publisher Informa Healthcare
Specialty Pulmonary Medicine
Date 1990 Sep 1
PMID 2226354
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

In any 24-h period the body temperature (Tb) of the central Australian agamid lizard, Ctenophorus nuchalis, may vary from 13 to 45 degrees C; the mean preferred Tb is 37 degrees C. We have analyzed surfactant-type lipids in lizards that underwent rapid changes in Tb from 37 degrees C to 14, 19, 27, or 44 degrees C. Lipids were extracted from lung lavage and lamellar body fractions, and phospholipids and cholesterol components were measured. There was no change in either the total amount or relative proportions of the different classes of phospholipids, but cooling increased the cholesterol content of lavage. An increase in the cholesterol: phospholipid ratio was evident within 2 h of cooling to 19 degrees C and was maintained for at least 48 h. The ratio increased from 8% at 37 degrees C, to 15% after 4 h at 19 degrees C, and 18% after 4 h at 14 degrees C. Possibly the increase in cholesterol promotes fluidity and absorption of surfactant within the alveoli of lizards with low Tb. Cold lizards collapse their lungs during prolonged periods of apnea and the surfactant may prevent the epithelial walls from adhering.

Citing Articles

Autoimmune Pulmonary Alveolar Proteinosis.

McCarthy C, Carey B, Trapnell B Am J Respir Crit Care Med. 2022; 205(9):1016-1035.

PMID: 35227171 PMC: 9851473. DOI: 10.1164/rccm.202112-2742SO.


Lipid profiling suggests species specificity and minimal seasonal variation in Pacific Green and Hawksbill Turtle plasma.

Clyde-Brockway C, Ferreira C, Flaherty E, Paladino F PLoS One. 2021; 16(7):e0253916.

PMID: 34280208 PMC: 8289036. DOI: 10.1371/journal.pone.0253916.


The Alveolar Lipidome in Pulmonary Alveolar Proteinosis. A New Target for Therapeutic Development?.

Trapnell B, McCarthy C Am J Respir Crit Care Med. 2019; 200(7):800-802.

PMID: 31162934 PMC: 6812441. DOI: 10.1164/rccm.201905-1009ED.


Statin as a novel pharmacotherapy of pulmonary alveolar proteinosis.

McCarthy C, Lee E, Bridges J, Sallese A, Suzuki T, Woods J Nat Commun. 2018; 9(1):3127.

PMID: 30087322 PMC: 6081448. DOI: 10.1038/s41467-018-05491-z.


Targeting cholesterol homeostasis in lung diseases.

Sallese A, Suzuki T, McCarthy C, Bridges J, Filuta A, Arumugam P Sci Rep. 2017; 7(1):10211.

PMID: 28860566 PMC: 5579240. DOI: 10.1038/s41598-017-10879-w.